TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Spire Healthcare ( (GB:SPI) ) is now available.
Spire Healthcare reports a 3.6% revenue growth from July to October 2025, despite challenges from inflation and increased National Minimum Wage. The company is on track with its transformation program, aiming for £30m in savings, and has successfully launched Patient Support Centres to improve private patient trends. However, NHS commissioning activity slowdown due to budget restrictions poses a challenge. Spire expects FY25 EBITDA to be at the lower end of its guidance range and anticipates continued improvement in self-pay and PMI trends for FY26. The company has extended its banking facilities and is evaluating strategic options to drive shareholder value, including potential sales or increased focus on private payors.
The most recent analyst rating on (GB:SPI) stock is a Buy with a £2.75 price target. To see the full list of analyst forecasts on Spire Healthcare stock, see the GB:SPI Stock Forecast page.
Spark’s Take on GB:SPI Stock
According to Spark, TipRanks’ AI Analyst, GB:SPI is a Neutral.
Spire Healthcare’s overall stock score is driven by strong financial performance, particularly in revenue growth and operational efficiency. However, high leverage and low net profitability are concerns. Technical indicators suggest bearish momentum, and valuation metrics indicate potential overvaluation.
To see Spark’s full report on GB:SPI stock, click here.
More about Spire Healthcare
Spire Healthcare is a leading independent healthcare group in the UK, operating 38 hospitals and over 50 clinics, medical centres, and consulting rooms across England, Wales, and Scotland. It provides a range of services including private GP networks, occupational health services to over 800 corporate clients, and is the leading private provider of knee and hip operations in the UK. Spire also offers mental health, musculoskeletal, and dermatological services under the Vita Health Group brand, and is listed on the London Stock Exchange as a member of the FTSE 250.
Average Trading Volume: 1,198,396
Technical Sentiment Signal: Buy
Current Market Cap: £911.4M
See more insights into SPI stock on TipRanks’ Stock Analysis page.

